Rhumbline Advisers Zymergen Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.12 - $3.03 $100,896 - $272,960	-90,086 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.88 - $7.02 $11,237 - $27,392	3,902 Added 4.53%	90,086 $260,000
Q4 2021 Feb 10, 2022	BUY	$6.53 - $14.19 $419,905 - $912,473	64,304 Added 293.89%	86,184 $577,000
Q3 2021 Nov 12, 2021	BUY	$8.25 - $41.0 $7,012 - $34,850	850 Added 4.04%	21,880 $288,000
Q2 2021 Aug 05, 2021	BUY	$28.5 - $48.5 $599,355 - $1.02 Million	21,030 New	21,030 $841,000

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.